Copyright Licensing Agency Licence Certificate 2020-21

This is to certify that The Copyright Licensing Agency Limited (“CLA”) has granted a Licence...

View document

MHRA Phase I Accreditation Certificate (October 2023)

The accreditation is based on the Unit continuing to maintain satisfactory standards for avoiding harm to trial subjects and for handling medical emergencies should they arise.

View document

MHRA Phase I Accreditation Certificate (01 June 2022)

The accreditation is based on the Unit continuing to maintain satisfactory standards for avoiding harm to trial subjects and for handling medical emergencies should they arise.

View document

MHRA Phase I Accreditation Certificate (August 2020)

MHRA Phase I Accreditation Certificate (August 2020)

View document

MHRA Phase I Accreditation Certificate (April 2017)

MHRA Phase I Accreditation Certificate (April 2017)

View document

MHRA Phase I Accreditation Certificate (March 2015)

MHRA Phase I Accreditation Certificate (March 2015)

View document

MHRA Phase I Accreditation Certificate (March 2013)

MHRA Phase I Accreditation Certificate (March 2013)

View document

Corporate Accounts 2021

Corporate Accounts 2021

View document

Corporate Accounts 2020

Corporate Accounts 2020

View document

Corporate Accounts 2019

Corporate Accounts 2019

View document

Corporate Accounts 2018

Corporate Accounts 2018

View document

Latest news

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Patient with rare bleeding disorder becomes first to test new treatment

May 22, 2024
The thousands of patients who participate in Richmond’s trials are helping to advance medical science and save lives and, in the process, some make history. In a film released today, one trial participant tells her story.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event